Uncategorized

Two Clocks, One Drug: How Patents and FDA Exclusivity Actually Determine When Your Drug Faces Competition

Two clocks. One drug. And the difference between “protected” and “available” can be a matter of months—or a matter of strategy.
That’s the core tension behind the question many pharma leaders are asking right now: when does competition actually arrive?…

Two Clocks, One Drug: How Patents and FDA Exclusivity Actually Determine When Your Drug Faces Competition Read Post »

Biotechblog
Scroll to Top